Literature DB >> 26670425

Lymphadenopathies in patients with renal cell carcinoma: clinical and pathological predictors of pathologically confirmed lymph node invasion.

Umberto Capitanio1,2, Federico Deho'3, Paolo Dell'Oglio3,4, Alessandro Larcher3,4, Paolo Capogrosso3,4, Alessandro Nini3,4, Cristina Carenzi4, Massimo Freschi5, Alberto Briganti3,4, Andrea Salonia3,4, Francesco Montorsi3,4, Roberto Bertini3.   

Abstract

INTRODUCTION: In renal cell carcinoma (RCC), lymph node status at preoperative imaging is affected by a non-negligible false-positive rate. We aimed to investigate which factors are related to a concordance between clinical suspicion and pathological confirmation of lymph node invasion (LNI).
METHODS: At a single tertiary care institution, 2954 RCC patients underwent either partial or radical nephrectomy. For the aim of the study, only clinically positive lymph node cases were included (cN1). Statistical analyses assessed the concordance between preoperative and pathological nodal status.
RESULTS: Preoperative axial CT scans revealed 424 (14.4 %) patients showing at least one enlarged lymph node suspected for LNI (cN1). All lymphadenopathies were removed at surgery, and LNI was pathologically confirmed (pN1) in 122 patients (28.8 %). When focusing the analyses on clinical characteristics (variables known before surgery), metastases at diagnosis [OR 3.0 (95 %1.9-4.8), p < 0.001] and tumor size [OR 1.1 (95 % 1.1-1.2), p < 0.001] were the two most informative predictors of concordance between clinical and pathological nodal status. Concordance was also more likely in patients with papillary type II tumors (55.6 %) relative to papillary type I (38.1 %), clear cell (27.7 %) and chromophobe (8.3 %) tumors. At multivariable analyses, none of the considered blood markers resulted to be independently associated with LNI.
CONCLUSIONS: Roughly 70 % of patients showing a suspected lymph node preoperatively do not show LNI at the final pathological report. Among patients with clinically positive nodes, clinical tumor size and metastases at diagnosis represent the most informative and independent predictors of confirmed LNI at final pathology.

Entities:  

Keywords:  Lymph node dissection; Lymph node invasion; Lymphadenectomy; Renal cell carcinoma

Mesh:

Year:  2015        PMID: 26670425     DOI: 10.1007/s00345-015-1747-5

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  16 in total

Review 1.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

Review 2.  Lymph node dissection in renal cell carcinoma.

Authors:  Umberto Capitanio; Frank Becker; Michael L Blute; Peter Mulders; Jean-Jacques Patard; Paul Russo; Urs E Studer; Hein Van Poppel
Journal:  Eur Urol       Date:  2011-09-13       Impact factor: 20.096

3.  Evaluating the yield of medical tests.

Authors:  F E Harrell; R M Califf; D B Pryor; K L Lee; R A Rosati
Journal:  JAMA       Date:  1982-05-14       Impact factor: 56.272

4.  Concurrent RCC with tuberculous para-aortic lymphadenopathy: A pleasant surprise.

Authors:  Praveen Pushkar; Anshuman Agarwal; Ashok Sarin; Vikas Kashyap
Journal:  Can Urol Assoc J       Date:  2015 Mar-Apr       Impact factor: 1.862

Review 5.  EAU guidelines on renal cell carcinoma: 2014 update.

Authors:  Borje Ljungberg; Karim Bensalah; Steven Canfield; Saeed Dabestani; Fabian Hofmann; Milan Hora; Markus A Kuczyk; Thomas Lam; Lorenzo Marconi; Axel S Merseburger; Peter Mulders; Thomas Powles; Michael Staehler; Alessandro Volpe; Axel Bex
Journal:  Eur Urol       Date:  2015-01-21       Impact factor: 20.096

6.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

Authors:  E A Eisenhauer; P Therasse; J Bogaerts; L H Schwartz; D Sargent; R Ford; J Dancey; S Arbuck; S Gwyther; M Mooney; L Rubinstein; L Shankar; L Dodd; R Kaplan; D Lacombe; J Verweij
Journal:  Eur J Cancer       Date:  2009-01       Impact factor: 9.162

7.  Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881.

Authors:  Jan H M Blom; Hein van Poppel; Jean M Maréchal; Didier Jacqmin; Fritz H Schröder; Linda de Prijck; Richard Sylvester
Journal:  Eur Urol       Date:  2008-10-01       Impact factor: 20.096

8.  Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma: a population-based perspective.

Authors:  Giovanni Lughezzani; Umberto Capitanio; Claudio Jeldres; Hendrik Isbarn; Shahrokh F Shariat; Philippe Arjane; Hugues Widmer; Paul Perrotte; Francesco Montorsi; Pierre I Karakiewicz
Journal:  Cancer       Date:  2009-12-15       Impact factor: 6.860

9.  Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases.

Authors:  U E Studer; S Scherz; J Scheidegger; R Kraft; R Sonntag; D Ackermann; E J Zingg
Journal:  J Urol       Date:  1990-08       Impact factor: 7.450

10.  Diagnostic accuracy of preoperative computed tomography used alone to detect lymph-node involvement at radical nephrectomy.

Authors:  Stephen S Connolly; Aditya Raja; Helen Stunell; Deepak Parashar; Sara Upponi; Anne Y Warren; Vincent J Gnanapragasam; Tim Eisen
Journal:  Scand J Urol       Date:  2015-01-26       Impact factor: 1.612

View more
  6 in total

1.  Valuation of lymph node dissection in localized high-risk renal cell cancer using X-tile software.

Authors:  Wei Zhuang; Jiabi Chen; Yining Li; Weihui Liu
Journal:  Int Urol Nephrol       Date:  2019-10-14       Impact factor: 2.370

2.  Accuracy of clinical nodal staging and factors associated with receipt of lymph node dissection at the time of surgery for nonmetastatic renal cell carcinoma.

Authors:  Kushan D Radadia; Zorimar Rivera-Núñez; Sinae Kim; Nicholas J Farber; Joshua Sterling; Marissa Falkiewicz; Parth K Modi; Sharad Goyal; Rahul Parikh; Robert E Weiss; Isaac Y Kim; Sammy E Elsamra; Thomas L Jang; Eric A Singer
Journal:  Urol Oncol       Date:  2019-07-05       Impact factor: 3.498

Review 3.  The rationale and the role of lymph node dissection in renal cell carcinoma.

Authors:  Umberto Capitanio; Bradley C Leibovich
Journal:  World J Urol       Date:  2016-06-30       Impact factor: 4.226

Review 4.  The contemporary role of lymph node dissection in the management of renal cell carcinoma.

Authors:  Piotr Zareba; Jehonathan H Pinthus; Paul Russo
Journal:  Ther Adv Urol       Date:  2018-08-20

5.  Predictive and prognostic effect of inflammatory lymphadenopathies in renal cell carcinoma.

Authors:  Fabio Muttin; Angela Pecoraro; Alessandro Larcher; Paolo Dell'Oglio; Alessandro Nini; Francesco Cianflone; Francesco Trevisani; Federico Dehò; Alberto Briganti; Andrea Salonia; Francesco Montorsi; Roberto Bertini; Umberto Capitanio
Journal:  World J Urol       Date:  2018-07-25       Impact factor: 4.226

6.  Dissecting the role of lymphadenectomy in the management of renal cell carcinoma: past, present, and future.

Authors:  Alain Kaldany; Zev R Leopold; Juliana E Kim; Hiren V Patel; Arnav Srivastava; Alexandra L Tabakin; Eric A Singer
Journal:  Kidney Cancer J       Date:  2020-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.